DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Cancan Luo(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Anamarija M. Perry(University of Michigan), Xiangshan Fan(Anhui Medical University), Eric D. Hsi(Mayo Clinic), Ali Sakhdari(University of Toronto), Alexandar Tzankov(University of Basel), Heounjeong Go(Ulsan College), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Qingyan Au(NeoGenomics (United States)), Wenting Song(Huazhong Agricultural University), Santiago Montes‐Moreno(Universidad de Cantabria), Dennis P. O’Malley(Ambry Genetics (United States)), Harry Nunns(NeoGenomics (United States)), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Aliyah R. Sohani(Massachusetts General Hospital), Yong Li(Baylor College of Medicine), Yu Li(Nanchang Institute of Science & Technology), Alyssa F. Yuan(Duke Medical Center), Carlo Visco(University of Verona), Bing Xu(Avera Health), Jeremy S. Abramson(Massachusetts General Hospital), N Wang(Duke Medical Center), Michael Møller(Hospital South West Jutland)
Cited by 2
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718